Skip to main content
Fig. 9 | BMC Medical Genomics

Fig. 9

From: CXCR3 predicts the prognosis of endometrial adenocarcinoma

Fig. 9

Development and validation of a new predictive nomogram and qPCR verification. A The predictive nomogram was used to predict the survival probability at one year, three years, and five years). B Calibration curves of the nomograms at one year, three years, and five years. The X-axis represents the predicted probability, and the Y-axis represents the actual probability. The error line represents a 95% confidence interval. 45° represents a perfect prediction and the excellent performance of our nomogram. C The qPCR verification of the relative expression of CXCR3 between the normal endometrium and the endometrial adenocarcinoma patients (t-test, P < 0.001)

Back to article page